1-8 of 8
Neville F. Hacker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 106: Shock and ROR! Targeting ROR1 and ROR2 in a preclinical patient-derived model of ovarian cancer

Claire E. Henry, Neville F. Hacker, Caroline E. Ford
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 106.
https://doi.org/10.1158/1538-7445.AM2018-106
Published: 01 July 2018
View article titled, Abstract 106: Shock and ROR! Targeting ROR1 and ROR2 in a preclinical patient-derived model of ovarian cancer
Journal Articles

Abstract 1636: The role of the ROR receptors in ovarian cancer progression and chemoresistance

Claire E. Henry, Estelle Llamosas, Neville F. Hacker, Viola Heinzelmann-Schwarz, Caroline E. Ford
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1636.
https://doi.org/10.1158/1538-7445.AM2016-1636
Published: 15 July 2016
View article titled, Abstract 1636: The role of the ROR receptors in ovarian cancer progression and chemoresistance
Journal Articles

Abstract 517: Anti-glycan IgM and IgG antibodies as new biomarkers for serous ovarian cancers

Brian WC Tse, Francis Jacob, Tatiana Pochechueva, Sheri Nixdorf, Andre Fedier, Margaret Huflejt, Nicolai Bovin, Daniel A. Fink, Neville F. Hacker, Viola A. Heinzelmann-Schwarz
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 517.
https://doi.org/10.1158/1538-7445.AM2012-517
Published: 15 April 2012
View article titled, Abstract 517: Anti-glycan IgM and IgG antibodies as new biomarkers for serous ovarian cancers
Journal Articles

The use of Galectin 4 and Meprin A as potential tumor markers of mucinous ovarian cancer

Viola A. Heinzelmann-Schwarz, Margaret Gardiner-Garden, Susan M. Henshall, James Scurry, Richard A. Scolyer, Alison Smith, Daniel A. Fink, Robert L. Sutherland, Neville F. Hacker, Philippa M. O’Brien
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 846.
Published: 01 May 2005
View article titled, The use of Galectin 4 and Meprin A as potential tumor markers of mucinous ovarian cancer
Journal Articles

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

Zhen Zhang, Robert C. Bast, Jr., Yinhua Yu, Jinong Li, Lori J. Sokoll, Alex J. Rai, Jason M. Rosenzweig, Bonnie Cameron, Young Y. Wang, Xiao-Ying Meng, Andrew Berchuck, Carolien van Haaften-Day, Neville F. Hacker, Henk W. A. de Bruijn, Ate G. J. van der Zee, Ian J. Jacobs, Eric T. Fung, Daniel W. Chan
Journal: Cancer Research
Cancer Res (2004) 64 (16): 5882–5890.
https://doi.org/10.1158/0008-5472.CAN-04-0746
Published: 16 August 2004
View article titled, Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer
Open the PDF for Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer in another window
Journal Articles

Simultaneous Suppression of Epidermal Growth Factor Receptor and c-erbB-2 Reverses Aneuploidy and Malignant Phenotype of a Human Ovarian Carcinoma Cell Line

Svetlana D. Pack, Özgül M. Alper, Kurt Stromberg, Meena Augustus, Metin Özdemirli, Anne M. Miermont, Greg Klus, Marek Rusin, Rebecca Slack, Neville F. Hacker, Thomas Ried, Zoltan Szallasi, Özge Alper
Journal: Cancer Research
Cancer Res (2004) 64 (3): 789–794.
https://doi.org/10.1158/0008-5472.CAN-03-1982
Published: 10 February 2004
View article titled, Simultaneous Suppression of Epidermal Growth Factor Receptor and c-erbB-2 Reverses Aneuploidy and Malignant Phenotype of a Human Ovarian Carcinoma Cell Line
Open the PDF for Simultaneous Suppression of Epidermal Growth Factor Receptor and c-erbB-2 Reverses Aneuploidy and Malignant Phenotype of a Human Ovarian Carcinoma Cell Line in another window
Includes: Supplementary data
Journal Articles

Intraperitoneal Recombinant α-Interferon for “Salvage” Immunotherapy in Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

Jonathan S. Berek, Neville F. Hacker, Alan Lichtenstein, Tyler Jung, Celsa Spina, Reba M. Knox, Jeanine Brady, Teri Greene, Lupe M. Ettinger, Leo D. Lagasse, Eric M. Bonnem, Robert J. Spiegel, Jacob Zighelboim
Journal: Cancer Research
Cancer Res (1985) 45 (9): 4447–4453.
Published: 01 September 1985
View article titled, Intraperitoneal Recombinant α-Interferon for “Salvage” Immunotherapy in Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
Open the PDF for Intraperitoneal Recombinant α-Interferon for “Salvage” Immunotherapy in Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study in another window
Journal Articles

Immunotherapy with Biochemically Dissociated Fractions of Propionibacterium acnes in a Murine Ovarian Cancer Model

Jonathan S. Berek, John L. Cantrell, Alan K. Lichtenstein, Neville F. Hacker, Reba M. Knox, Roberta K. Nieberg, Thanne Poth, Robert M. Elashoff, Leo D. Lagasse, Jacob Zighelboim
Journal: Cancer Research
Cancer Res (1984) 44 (5): 1871–1875.
Published: 01 May 1984
View article titled, Immunotherapy with Biochemically Dissociated Fractions of <em>Propionibacterium acnes</em> in a Murine Ovarian Cancer Model
Open the PDF for Immunotherapy with Biochemically Dissociated Fractions of <em>Propionibacterium acnes</em> in a Murine Ovarian Cancer Model in another window